Secretases Related to Amyloid Precursor Protein Processing [PDF]
Alzheimer’s disease (AD) is a common neurodegenerative disease whose prevalence increases with age. An increasing number of findings suggest that abnormalities in the metabolism of amyloid precursor protein (APP), a single transmembrane aspartic protein ...
Xiaoling Liu, Yan Liu, Shangrong Ji
doaj +7 more sources
Cholesterol-dependent amyloid β production: space for multifarious interactions between amyloid precursor protein, secretases, and cholesterol [PDF]
Amyloid β is considered a key player in the development and progression of Alzheimer’s disease (AD). Many studies investigating the effect of statins on lowering cholesterol suggest that there may be a link between cholesterol levels and AD pathology ...
Vladimir Rudajev, Jiri Novotny
doaj +4 more sources
Interactions between APP secretases and inflammatory mediators [PDF]
There is now a large body of evidence linking inflammation to Alzheimer's disease (AD). This association manifests itself neuropathologically in the presence of activated microglia and astrocytes around neuritic plaques and increased levels of ...
Gentleman Steve M +2 more
doaj +6 more sources
Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. [PDF]
Amyloid-beta (Abeta) peptides, found in Alzheimer's disease brain, accumulate rapidly after traumatic brain injury (TBI) in both humans and animals. Here we show that blocking either beta- or gamma-secretase, enzymes required for production of Abeta from amyloid precursor protein (APP), can ameliorate motor and cognitive deficits and reduce cell loss ...
Loane DJ +7 more
europepmc +6 more sources
Inhibition of amyloid precursor protein secretases reduces recovery after spinal cord injury. [PDF]
Amyloid-β (Aβ) is produced through the enzymatic cleavage of amyloid precursor protein (APP) by β (Bace1) and γ-secretases. The accumulation and aggregation of Aβ as amyloid plaques is the hallmark pathology of Alzheimer׳s disease and has been found in other neurological disorders, such as traumatic brain injury and multiple sclerosis.
Pajoohesh-Ganji A +6 more
europepmc +6 more sources
A synapse perspective on the function of the amyloid precursor protein [PDF]
The amyloid precursor protein (APP) is a transmembrane protein widely expressed throughout the brain, where it plays critical roles in both physiological and pathological states.
Pia Kruse +3 more
doaj +2 more sources
Secretase promotes AD progression: simultaneously cleave Notch and APP [PDF]
Alzheimer’s disease (AD) involves complex pathological mechanisms. Secretases include membrane protein extracellular structural domain proteases and intramembrane proteases that cleave the topology to type I or type II.
Ke-Fan Yang +7 more
doaj +2 more sources
A perspective: PLA2G4A as drug target for vascular inflammation in Alzheimer's disease. [PDF]
Abstract Anti‐amyloid therapies for Alzheimer's disease (AD) modestly slow cognitive decline but carry significant risk of amyloid‐related imaging abnormalities (ARIAs), brain swelling, and hemorrhage, particularly in apolipoprotein E ε4 carriers. Cerebral amyloid angiopathy (CAA) and vascular inflammation drive this vulnerability, highlighting the ...
Kanwal A +12 more
europepmc +2 more sources
lncRNAs: key player in Aβ deposition [PDF]
Alzheimer’s disease (AD) is a typical neurodegenerative disorder, characterized by the deposition of β-amyloid (Aβ) plaques. β- and γ-secretases generate Aβ by cleaving amyloid precursor protein.
Ruo-Mei Wang, Zi-Qiang Wang
doaj +2 more sources
Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation [PDF]
In sporadic age-related forms of Alzheimer's disease (AD), it is unclear why amyloid-β (Aβ) peptides accumulate. Here we show that soluble amyloid precursor protein-α (sAPP-α) decreases Aβ generation by directly associating with β-site APP-converting enzyme (BACE)1, thereby modulating APP processing.
Demian Obregon +10 more
openalex +3 more sources

